en
Scientific article
Open access
English

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 — epidemiology, pathophysiology, and diagnosis

ContributorsTask Force for the management of COVID-19 of the European Society of Cardiology
CollaboratorsRoffi, Marco
Published inEuropean heart journal, vol. 43, no. 11, p. 1033-1058
Errata
Publication date2022-03
First online date2021-11-16
Abstract

Aims: Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two-part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular disease (CVD) in association with COVID-19.

Methods and results: A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, reported here, focuses on the epidemiology, pathophysiology, and diagnosis of cardiovascular (CV) conditions that may be manifest in patients with COVID-19. The second part, which will follow in a later edition of the journal, addresses the topics of care pathways, treatment, and follow-up of CV conditions in patients with COVID-19.

Conclusion: This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.

eng
Keywords
  • ACE2
  • Arrhythmias
  • Biomarkers
  • COVID-19
  • Cardiogenic shock
  • Myocardial injury
  • Myocarditis
  • Non-invasive imaging
Funding
  • National Institute for Health Research (NIHR) - [17/140/02]
Citation (ISO format)
Task Force for the management of COVID-19 of the European Society of Cardiology. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 — epidemiology, pathophysiology, and diagnosis. In: European heart journal, 2022, vol. 43, n° 11, p. 1033–1058. doi: 10.1093/eurheartj/ehab696
Main files (1)
Article (Published version)
accessLevelPublic
Updates (1)
Corrigendum
accessLevelPublic
Identifiers
ISSN of the journal0195-668X
135views
12downloads

Technical informations

Creation02/21/2022 3:36:00 PM
First validation02/21/2022 3:36:00 PM
Update time03/16/2023 8:56:43 AM
Status update03/16/2023 8:56:41 AM
Last indexation02/01/2024 9:10:38 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack